同成医药 (837062.OC)

+ 收藏

现金流量表(同成医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 128,344,631.26250,865,072.49135,869,542.69404,472,116.34219,243,832.58
 收到的税费返还(元) 3,996,553.4824,425,588.7311,106,967.7629,626,961.4413,751,300.38
 收到其他与经营活动有关的现金(元) 7,968,462.471,750,097.79672,324.926,711,490.375,882,451.06
 经营活动现金流入小计(元) 140,309,647.21277,040,759.01147,648,835.37440,810,568.15238,877,584.02
 购买商品、接受劳务支付的现金(元) 36,875,663.12204,411,768.89131,506,573.52289,244,425.40176,736,627.78
 支付给职工以及为职工支付的现金(元) 16,172,072.6844,002,188.7425,011,344.4640,853,616.5719,141,656.62
 支付的各项税费(元) 1,436,003.572,134,292.001,123,201.1221,296,238.4510,136,382.85
 支付其他与经营活动有关的现金(元) 3,889,081.108,443,593.183,755,909.6028,368,012.5018,078,280.17
 经营活动现金流出小计(元) 58,372,820.47258,991,842.81161,397,028.70379,762,292.92224,092,947.42
 经营活动产生的现金流量净额(元) 81,936,826.7418,048,916.20-13,748,193.3361,048,275.2314,784,636.60
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 148,000.0011,500.0010,176.9913,975,934.3820,329,879.00
 投资活动现金流入小计(元) 148,000.0011,500.0010,176.9913,975,934.3820,329,879.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 12,451,861.16202,968,118.64135,089,907.39192,497,873.1357,584,694.55
 投资活动现金流出小计(元) 12,451,861.16202,968,118.64135,089,907.39192,497,873.1357,584,694.55
 投资活动产生的现金流量净额(元) -12,303,861.16-202,956,618.64-135,079,730.40-178,521,938.75-37,254,815.55
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 50,410,000.00287,485,540.00213,415,720.00204,755,000.0071,235,000.00
 收到其他与筹资活动有关的现金(元) 47,113,187.92----
 筹资活动现金流入小计(元) 97,523,187.92287,485,540.00213,415,720.00204,755,000.0071,235,000.00
 偿还债务支付的现金(元) 175,035,720.00104,700,000.0058,660,000.0055,000,000.0020,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 7,591,100.1912,889,177.545,476,624.0920,689,479.1717,590,799.95
 筹资活动现金流出小计(元) 182,626,820.19117,589,177.5464,136,624.0975,689,479.1737,590,799.95
 筹资活动产生的现金流量净额(元) -85,103,632.27169,896,362.46149,279,095.91129,065,520.8333,644,200.05
四、汇率变动对现金及现金等价物的影响(元) -3,566.06-66,206.28144,912.511,260,959.31715,394.71
五、现金及现金等价物净增加额(元) -15,474,232.75-15,077,546.26596,084.6912,852,816.6211,889,415.81
 加:期初现金及现金等价物余额(元) 20,929,233.2236,006,779.4836,006,779.4823,153,962.8623,153,962.86
 期末现金及现金等价物余额(元) 5,455,000.4720,929,233.2236,602,864.1736,006,779.4835,043,378.67
补充资料:
 净利润(元) 3,136,394.27-21,499,881.29-10,378,216.3796,661,006.6173,054,708.56
 资产减值准备(元) -8,791,442.427,538,170.19483,914.73-401,837.85
 固定资产和投资性房地产折旧(元) 28,018,923.0451,023,426.3023,863,624.3622,810,737.01-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 28,018,923.0451,023,426.3023,863,624.3622,810,737.01-
 无形资产摊销(元) 1,150,680.362,311,531.431,158,590.202,345,196.781,186,570.32
 处置固定资产、无形资产和其他长期资产的损失(元) -70,246.84-9,097.25-9,097.25-2,209,745.40-2,197,356.02
 固定资产报废损失(元) 76,676.23612,932.51311,968.57131,868.0037,171.98
 财务费用(元) 6,302,510.7811,103,912.264,514,779.802,480,434.29476,386.57
 递延所得税(元) -342,051.07-5,598,320.79-2,845,337.041,844,003.2638,883.46
  其中:递延所得税资产减少(元) 77,290.67-8,264,372.35-2,618,023.57134,363.9090,941.83
 递延所得税负债增加(元) -419,341.742,666,051.56-227,313.471,709,639.36-52,058.37
 存货的减少(元) -9,943,510.09-1,904,536.00-12,095,130.38-1,733,226.91-6,245,801.53
 经营性应收项目的减少(元) -50,167,378.27-74,466,040.79-72,312,858.74-38,971,413.78-71,225,720.41
 经营性应付项目的增加(元) 102,818,611.1947,816,129.5546,437,143.99-21,802,786.3014,056,327.70
 现金的期末余额(元) 5,455,000.4720,929,233.2236,602,864.1736,006,779.4835,043,378.67
 减:现金的期初余额(元) 20,929,233.2236,006,779.4836,006,779.4823,153,962.8623,153,962.86
 现金及现金等价物的净增加额(元) -15,474,232.75-15,077,546.26596,084.6912,852,816.6211,889,415.81
公告日期 2024-08-232024-04-162023-08-282023-03-032022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院